Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 17, 2026

Pulsar Helium Appoints Stephen Lange Ranzini to the Board of Directors and as Deputy Chair

View original at globenewswire.com
Pulsar Helium Appoints Stephen Lange Ranzini to the Board of Directors and as Deputy Chair THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFR…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Pulsar is the first mover in both Minnesota and Greenland locations with primary helium occurrences not associated with hydrocarbon production

    60% confidence
  • Ongoing hostilities in the region have highlighted the vulnerability of global helium supply chains

    60% confidence
  • Qatar accounts for approximately a third of global helium production, with exports reliant on shipping routes through the Strait of Hormuz

    60% confidence
  • UNIB has already demonstrated strong support for Pulsar, holding approximately 4.99% of the Company's issued share capital, providing a US$4 million line of credit to support development activities at our Topaz project, and expressing its intention to potentially finance up to US$12.5 million for a helium processing facility.

    60% confidence
  • Assisting Pulsar to complete exploration and preparations for potential development of the Topaz Project into production is a national economic and national security imperative

    60% confidence
  • Stephen Lange Ranzini brings deep U.S. financial market expertise, extensive institutional relationships, and a highly accomplished leadership record

    60% confidence
  • Stephen Ranzini's appointment represents an important strengthening of Pulsar's senior leadership in the United States

    60% confidence
  • Stephen brings deep U.S. financial market expertise, extensive institutional relationships, and a highly accomplished leadership record. As CEO of University Bank, he has overseen its development into one of the top-performing banks in the United States.

    60% confidence
  • Qatar accounts for approximately a third of global helium production, with exports reliant on shipping routes through the Strait of Hormuz. Ongoing hostilities in the region have highlighted the vulnerability of global helium supply chains.

    60% confidence
  • Stephen's appointment represents an important strengthening of Pulsar's senior leadership in the United States as we continue to build out a top-tier American leadership bench to support the development of our projects and capital markets profile.

    60% confidence
  • Stephen's strategic perspective and experience across banking, capital markets and financial infrastructure will provide valuable guidance as Pulsar continues advancing its assets and positioning the Company to deliver long-term value for shareholders.

    60% confidence
  • UNIB has expressed intention to potentially finance up to US$12.5 million for a helium processing facility

    60% confidence
  • UNIB holds approximately 4.99% of Pulsar's issued share capital

    60% confidence
  • Stephen Ranzini has overseen University Bank's development into one of the top-performing banks in the United States

    60% confidence
  • Assisting Pulsar to complete the exploration program at its Topaz Project to quantify the size of the discovery and preparations for potential development of the Topaz Project into production as quickly as possible is now a national economic and national security imperative.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Pulsar Helium Appoints Stephen Lange Ranzini to the Board of Directors and as Deputy Chair — Source | Via News | Via News